medroxyprogesterone acetate has been researched along with Thrombopenia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Yehuda, D; Katz, D; Meirow, D; Or, R; Rabinovici, J; Shufaro, Y | 1 |
| Pedrazzoli, P | 1 |
| Fowler, R; Imrie, K | 1 |
1 trial(s) available for medroxyprogesterone acetate and Thrombopenia
| Article | Year |
|---|---|
Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Leukopenia; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Random Allocation; Rectal Neoplasms; Thrombocytopenia; Time Factors | 1986 |
3 other study(ies) available for medroxyprogesterone acetate and Thrombopenia
| Article | Year |
|---|---|
Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Menorrhagia; Neoplasms; Retrospective Studies; Thrombocytopenia; Triptorelin Pamoate | 2006 |
Myeloprotective effect of medroxyprogesterone acetate (MPA)
Topics: Cell Count; Hematopoietic Stem Cells; Humans; Leukopenia; Medroxyprogesterone Acetate; Thrombocytopenia | 1993 |
Thalidomide-associated hepatitis: a case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dexamethasone; Doxorubicin; Estrogens, Conjugated (USP); Fatal Outcome; Female; Hepatitis C; Humans; Leukemia, Plasma Cell; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Salvage Therapy; Thalidomide; Thrombocytopenia; Vincristine | 2001 |